These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16765491)

  • 1. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response.
    Mukhopadhaya A; Mahalanabis D; Chakrabarti MK
    Vaccine; 2006 Aug; 24(33-34):6028-36. PubMed ID: 16765491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
    Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
    Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
    Pore D; Chakrabarti MK
    Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer Membrane Vesicles Derived from
    Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
    Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition.
    Mukhopadhaya A; Mahalanabis D; Khanam J; Chakrabarti MK
    Vaccine; 2003 Jun; 21(21-22):3043-50. PubMed ID: 12798648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice.
    Camacho AI; de Souza J; Sánchez-Gómez S; Pardo-Ros M; Irache JM; Gamazo C
    Vaccine; 2011 Oct; 29(46):8222-9. PubMed ID: 21911022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
    Mitra S; Chakrabarti MK; Koley H
    Vaccine; 2013 Jun; 31(31):3163-73. PubMed ID: 23684822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated and subunit vaccines to prevent shigellosis.
    Kaminski RW; Oaks EV
    Expert Rev Vaccines; 2009 Dec; 8(12):1693-704. PubMed ID: 19943764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies.
    Camacho AI; Souza-Rebouças J; Irache JM; Gamazo C
    Methods; 2013 May; 60(3):264-8. PubMed ID: 23046911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
    Tribble D; Kaminski R; Cantrell J; Nelson M; Porter C; Baqar S; Williams C; Arora R; Saunders J; Ananthakrishnan M; Sanders J; Zaucha G; Turbyfill R; Oaks E
    Vaccine; 2010 Aug; 28(37):6076-85. PubMed ID: 20619378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Approach to Identify and Characterize a Subunit Candidate Shigella Vaccine Antigen.
    Pore D; Chakrabarti MK
    Methods Mol Biol; 2016; 1403():433-44. PubMed ID: 27076146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
    Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
    Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on virulence of Shigella flexneri. Protective effect of outer membrane proteins.
    Mulczyk M; Adamus G; Witkowska D; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):85-90. PubMed ID: 7025793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella.
    Witkowska D; Mulczyk M; Adamus G
    Arch Immunol Ther Exp (Warsz); 1985; 33(5):625-8. PubMed ID: 3914866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
    Roberts F; Jennison AV; Verma NK
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model.
    Yagnik B; Sharma D; Padh H; Desai P
    Vaccine; 2019 May; 37(23):3097-3105. PubMed ID: 31047673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of immunity by means of spleen cells from mice immunized with outer membrane proteins of Shigella flexneri.
    Witkowska D; Mleczko J; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1985; 33(5):629-35. PubMed ID: 3914867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.